Drug Screening Market: Current Analysis and Forecast (2021-2027)

$3999$7577

Emphasis on Product and Services (Drug Screening Products, Drug Screening Services); Sample (Urine Samples, Oral Fluid Samples, Breath Samples, Hair Samples, Others); End-Users (Hospitals & Clinics, Dialysis Centers, Others); Region and Country

Pages:

187

Table:

52

Figure:

135

Report ID:

UMHE21367

Clear
  Get a Free Sample
SKU: UMHE21367 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Drug Screening Market
Drug Screening Market

Drug screening is a method of detecting illegal and prescription drugs in blood, urine, and other bodily fluids. It’s also used to figure out how much of a drug you’re using, and it’s an important aspect of continuing evaluation and treatment. The market is being driven by a rise in the abuse of prescribed pharmaceuticals, as well as an increase in the use of opioids and illicit drugs. As per Our World in Data, illicit drug usage causes approximately 750,000 fatalities per year, both directly and indirectly. Illicit drug use causes 585,000 fatalities per year by raising the risk of sickness and injury. Moreover, according to the CDC, over 166,000 people died from drug overdoses in 2018. In the United States, there were 67,367 drug overdose deaths in 2018, down 4.1 percent from 2017. (70,237 deaths). The age-adjusted rate of drug overdose deaths was 20.7 per 100,000 in 2018, down 4.6 percent from 2017. (21.7). The drug overdose death rate was lower in 14 states and the District of Columbia in 2018 than it was in 2017. This has boosted the demand for drug and alcohol testing is expected to increase in the coming years.

In 2020, it was estimated that around 5.4% of the global population uses illicit drugs. Use of illicit drugs varies by country and region as countries enact their own laws regarding such substances. Worldwide, cannabis is by far the most used type of illicit drug, followed by opioids and amphetamines. Furthermore, as per World Drug Report, practice of injecting drugs accounted for roughly 10 per cent of HIV infections worldwide in 2018. Out of which, more than 1 million people who inject drugs have been living with HIV and 5.5 million are living with hepatitis C.

Number of past year users in millions, 2018

Drug Screening Market
Drug Screening Market

Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings are some of the prominent players operating in the global Drug Screening market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst product and services, drug screening products segment holds the major share”

Based on product, the global Drug Screening market is bifurcated into drug screening products and drug screening services. The drug screening products segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the increased prevalence of chronic viral infections has been increasing the demand for rapid testing. For instance, as per the Unicef.org, of the estimated 38.0 million people living with HIV worldwide in 2020, 2.78 million were children aged 0-19.

“Amongst sample, urine sample is anticipated to grow at the highest CAGR during the analyzed period”

Further based on sample, the market is fragmented into urine samples, oral fluid samples, breath samples, hair samples, and other samples. In 2020, urine samples accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to increased prevalence of kidney and bladder diseases. For instance, bladder cancer (BC) is the tenth most common cancer worldwide, with approximatively 550,000 new cases and 200,000 deaths in 2018. The incidence is 9.6 and 2.4 per 100,000 in males and females, respectively.

 “Amongst end-users, hospitals and clinics segment is anticipated to grow at the highest CAGR during the analyzed period”

Based on end-users, the market is fragmented into hospitals and clinics, dialysis centers, and other end-users. In 2020, hospitals and clinics accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory. For instance, 56% of U.S. employers require workers to take pre-employment drug tests, according to Statistic Brain. The annual cost to American companies for drug testing is about USD 3,750,500,000.

“North America signifies one of the largest markets of Drug Screening Market”

For a better understanding of the market dynamics of the Drug Screening market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the rise in number of traffic accidents due to driving while overdose of drug and alcohol consumption. For instance, according to the most recent data from the National Highway Traffic Safety Administration, there were a total of 10,874 fatalities in motor vehicles involving drivers with blood alcohol concentrations (BACs) of .08 g/dL (grams per deciliter) or higher in 2017 in the United States. However, Asia is expected to register the highest CAGR during the forecast period owing to the growing burden of accidents due to unsafe levels of alcohol consumption.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Drug Screening Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

 1.1Market Definitions
 1.2Objective of the Study
 1.3Limitation
 1.4Stake Holders
 1.5Currency Used in Report
 1.6Scope of the Global Drug Screening Market Study

 

 2.1Research Methodology for the Global Drug Screening Market
  2.1.1Main Objective of the Global Drug Screening Market

 

 8.1Drug Screening Products
  8.1.1Analytical Instruments
   8.1.1.1Immunoassay Analyzers
   8.1.1.2Chromatography Instruments
   8.1.1.3Breathalyzers
  8.1.2Rapid Testing Devices
   8.1.2.1Urine Testing Devices
   8.1.2.2Oral Fluid Testing Devices
  8.1.3Consumables
  8.1.3Assay Kits
  8.1.4Sample Collection Tubes
  8.1.5Calibrators & Controls
  8.1.6Other Consumables
 8.2Drug Screening Services

 

 9.1Urine Samples
 9.2Oral Fluid Samples
 9.3Breath Samples
 9.4Hair Samples
 9.5Other Samples

 

 10.1Workplaces
 10.2Drug Testing Laboratories
 10.3Criminal Justice Systems & Law Enforcement Agencies
 10.4Hospitals
 10.5Drug Treatment Centers
 10.6Individual Users
 10.7Pain Management Centers
 10.8Schools & Colleges

 

 11.1NORTH AMERICA DRUG SCREENING MARKET 
  11.1.1United States
  11.1.2Canada 
  11.1.3Rest of North America
 11.2EUROPE DRUG SCREENING MARKET 
  11.2.1Germany 
  11.2.2France 
  11.2.3United Kingdom
  11.2.4Spain 
  11.2.5Italy 
  11.2.6Rest of Europe
 11.3ASIA PACIFIC DRUG SCREENING MARKET
  11.3.1China 
  11.3.2Japan 
  11.3.3India 
  11.3.4Australia 
  11.3.5Rest of Asia Pacific
 11.4REST OF THE WORLD DRUG SCREENING MARKET 

 

 12.1Market Drivers 
 12.2Market Challenges
 12.3Impact Analysis

 

 14.1Demand Side Analysis
 14.2Supply Side Analysis
  14.2.1Top Product Launches
  14.2.2Top Business Partnerships
  14.2.3Top Merger & Acquisitions
 18.1Porter’s Five forces analysis
  18.1.1Bargaining power of Supplier
  18.1.2Bargaining power of Buyer
  18.1.3Industry Rivalry
  18.1.4Availability of Substitute
  18.1.5Threat of new Entrants
 18.2Competitive Landscape
  19.2.1Company Shares, By Revenue
 19.1Thermo Fisher
  19.1.1Key Facts
  19.1.2Business Description
  19.1.3Key Product/Services Offerings
  19.1.4Growth Strategy
  19.1.5SWOT Analysis
  19.1.6Key Financials
   19.1.6.1
   19.1.6.2
  19.1.7Recent Developments
   19.1.7.1
   19.1.7.2
   19.1.7.3
   19.1.7.4
 19.2Siemens  
 19.3LabCorp 
 19.4 Alere 
 19.5Omega Laboratories
 19.6Roche 
 19.7OraSure 
 19.8Biomedical Diagnostics
 19.9Quest Diagnostics
 19.10Laboratory Corporation of America Holdings

 

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Drug Screening Market were the three major steps undertaken to create and analyze the adoption of Drug Screening due to increased consumption of alcohol and illicit drugs. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Drug Screening sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Drug Screening through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Drug Screening market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are technology and application. Further country-level analyses were conducted to evaluate the overall adoption of Drug Screening in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Drug Screening. Further, we conducted factor analysis using dependent and independent variables such as increasing demand for organic food and the growing population. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the Drug Screening industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Drug Screening market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of Drug Screening across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Drug Screening market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Drug Screening Market
Drug Screening Market

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Drug Screening market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the technology and application end-user of the Drug Screening market.

Main Objective of the Drug Screening Market Study

The current & future market trends of Drug Screening were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Drug Screening in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product & services, sample, and end users
  • Define and analysis of the regulatory framework for the Drug Screening industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the Drug Screening market for the major region
  • Major regions studied in the report include North America (the United States, and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia), and Rest of the World
  • Company profiles of the Drug Screening market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry